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ABSTRACT 
Background: In every year millions of people were affected by the Urinary Tract Infection. It was creating a serious health issue.  
Aim: The present study was to analysis of the uropathogenic bacteria in patients were attended RMMC Hospital and their antibiotic resistance 
pattern, in vitro detection of haemolysis virulent factor of uropathogenic.  
Material and Methods: All urine samples were tested by the standard microbiological procedure. Kirby-Bauer method used for the Antibiotic 
Susceptibility Test according to the CLSI guidelines. Commercially available antibiotics were used. Blood Agar used for the detection of 
haemolysis.  
Results: A total of 261 urine samples were included in this study. We isolated a total of 103 positive cultures. 12% of Gram-positive, 83% of 
Gram-negative bacteria and 3% of Candida fungi. Escherichia coli was the most predominant bacteria (54%) followed by Klebsiella sp (15%), 
Staphylococcus aureus (12%), Pseudomonas aeruginosa (12%), Proteus (1%) and fungi Candida (3%). Mostly female patients’ sample were 
analysed and the inpatient higher majority than the outpatients.  
Conclusion: Escherichia coli are the common bacteria to cause of UTI. Nowadays most of the uropathogens are to resistance to the overall 
antibiotics. This kind of reactions creating the life-threatening of humans. 
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INTRODUCTION 
UTI is the most common bacterial infection. It is the 
prevalent complication of pregnancy that can worsen 
maternal and prenatal prognosis. Untreated asymptomatic 
forms can progress to pyelonephritis, appropriate therapy to 
need the current knowledge of the organism that causes 
UTIs and their antibiotic susceptibility pattern1.  
Treatment of infectious diseases, depend upon repeated 
administration of an antibiotic, most of the microbial 
pathogens generate the resistance to antibiotics. Multiple 
drug resistance is also a widespread problem2. The 
prevalence and antimicrobial resistance pattern may differ 
between different places, different environmental factors the 
local data about the antimicrobial resistance of 
uropathogens data used for proper therapeutic treatment of 
UTI.  
The present study was undertaken to assess the 
antimicrobial resistance pattern among uropathogens to 
determine the virulence factor for UTI in Rajah Muthaiah 
Medical College & Hospital (RMMCH), Annamalai University, 
Chidambaram. 
MATERIALS AND METHODS: 
Design & Study: 
The study was carried out in the Department of 
Microbiology, Faculty of Science, Annamalai University, 
RMMCH Chidambaram, Tamil Nadu from July 2018 to 
December 2018. The analysed data generated from the 
register records of urine samples received in the Medical 
Microbiology laboratory from the hospital’s indoor and 
outdoor patients during the study period. Only one sample 
from each individual.  
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Analysis of antibiotic susceptibility test of all isolates was 
reviewed. Mostly midstream clean-catch urine samples were 
collected and processed 3. The isolates were identified 
according to the microbiological standard guidelines 4,5. All 
urine samples were inoculation done by using the calibrated 
loop technique. It delivered 0.005ml of urine onto HiCrome 
UTI Agar containing Petri plates (M1353R Himedia) and 
were incubated for 24 hours at 37℃. HiCrome UTI Agar is a 
differential medium recommended for presumptive 
identification of microorganisms mainly causing urinary 
tract infections.  
The common symptoms of urinary tract infection are urge to 
urine and frequency of micturition and discomfort or pain 3, 
6, 7. The urine cultures were interpreted depending upon the 
number of growth of colonies. Below 50 colonies 
(insignificant), above 50 to below 500 colonies (doubtful 
significance), above or equal 500 colonies (significant) with 
the clinical correlation as per recommendation. Escherichia 
coli ATCC 25922, Enterococcus faecalis ATCC 29212 were 
used as control 8,9. 
Blood Agar Base, modified (M1989-Himedia) is a nutritious 
basal medium used for preparing blood agar with blood. It 
also helps to detect the haemolytic reactions 10, 11. 
RESULTS: 
A total of 261 urine samples were included in this study. 
36% of Male Patients (n=94), 64% of Female patients shown 
in Fig.1(a). 12Similarly some author isolated 102 E. coli UTI 
isolates were obtained from urine samples of patients at the 
Princess Alexandra Hospital (Brisbane, Australia).  
Among the 261 samples, 191 samples were Inpatients 
including 79 male, 112 females; 70 samples were 
Outpatients including 15 male, 55 females shown in Fig.1(b). 
Age wise categories labelled as 1-5 (A), 6-10 (B), 11-15 (C), 
16-20 (D), 21-25 (E), 26-30 (F), 31-35 (G), 36-40 (H), 41-45 
(I), 46-50 (J), 51-55 (K), 56-60 (L), 61-65 (M), 66-70 (N), 71-
75 (O), 76-80 (P), 81-85 (Q) were shown in Fig. 1 (c). Out of 
these, 85 (32.56%) were sterile, 32 (12.26%) showed 
contaminated, 41 (15.70%) showed insignificant growth, 
103 (39.46%) showed significant growth Fig.1 (d). 
 
 
             Figure 1(a)   (Male n= 94, 36%), (Female n=167, 64%)                                                     Figure 1(b) 
 
Figure 1(c)                                                       Figure 1(d) 
Out of these, 85 (32.56%) were sterile that means no growth 
detected, Inpatients male was majority Fig.2(a). 32 (12.26%) 
showed contaminated that means unwanted growth 
detected due to the sample collection and transport error, 
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Inpatients female majority Fig.2(b). 41 (15.70%) showed 
insignificant growth reason for below 50 colonies on the 
plate, the high majority was female inpatients Fig.2(c). 103 
(39.46%) showed significant growth, mostly isolated from 
the female samples Fig.2(d). 
 
 
Figure 2 (a)                                                                 Figure 2(b) 
 
Figure 2 (c)                                       Figure 2 (d) 
 
We isolated a total of 103 positive cultures. 12.62% of Gram-
positive (n=13), 83.49% of Gram-negative (n=86) bacteria 
and 3.83% of Candida (n=4) fungi Fig.3(a).  Escherichia coli 
was the most predominant bacteria (54.36%) Fig.3(b) 
followed by Klebsiella sp (15.53%) Fig.3(c), Pseudomonas 
aeruginosa (12.62%) Fig.3(d), Staphylococcus aureus 
(12.62%) Fig.3(e), Proteus (0.97%) Fig.3(f) and additionally 
detected fungi Candida (3.88%). 
Mostly female patients’ sample were analysed and the 
inpatient higher majority than the outpatients.  The 
uropathogenic bacterium, which most frequently is 
Escherichia coli, but sometimes Staphylococcus saprophyticus 
or especially in hospital-acquired infections, Klebsiella 
species, Proteus mirabilis, Pseudomonas aeruginosa, 
Enterococcus faecalis. HiCrome UTI Agar is formulated for 
detection of uropathogens 3, 6, 7, 13, 14. 
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Different antibiotics were used for the AST based on the 
identification of the isolates. Amikacin (AK-30mcg), 
Amoxyclav (AMC-30mcg), Ampicillin/Sulbactam (A/S-
10/10mcg), Aztreonam (AT-30mcg), Cefaclor (CF-30mcg), 
Cefazolin (CZ-30mcg), Cefoperazone (CPZ-75mcg), 
Cefotaxime (CTX-30mcg), Ceftazidime (CAZ-30mcg), 
Ceftriaxone (CTR-30mcg), Cefuroxime (CXM-30mcg, 
Chloramphenicol (C-30mcg), Ciprofloxacin (CIP-5mcg), 
Clindamycin (CD-2mcg), Co-Trimoxazole 
(Trimethoprim/Sulphamethoxazole) (COT-25(1.25/23.75) 
mcg), Erythromycin (E-15mcg), Gentamicin (GEN-10mcg), 
Imipenem (IMP-10mcg), Linezolid (LZ-15mcg), Meropenem 
(MRP-10mcg), Nalidixic acid (NA-30mcg), Nitrofurantoin 
(NIT-300mcg), Nitrofurazone (NR-100mcg), Norfloxacin 
(NX-10mcg), Ofloxacin (OF-5mcg), Oxacillin (OX-1mcg), 
Piperacillin/Tazobactam (PIT-100/10mcg), Tetracycline 
(TE-30mcg), Tobramycin (TOB-10mcg) (Himedia). 
E.coli resistance to 19% Ampicillin/Sulbactam, 14% Co-
Trimoxazole, 14% Nalidixic acid, 12% Cefuroxime, 11% 
Cefoperazone, 10% Cefotaxime, 8% Gentamicin, 7% 
Ciprofloxacin, 2% Cefaclor, 2% Nitrofurantoin, 1% Amikacin 
Fig.4(a). Klebsiella resistance to 18% Ampicillin/Sulbactam, 
14% Cefoperazone, 13% Cefuroxime, 12% Cefotaxime, 12% 
Co-Trimoxazole, 10% Nalidixic acid, 9% Nitrofurantoin, 6% 
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Ciprofloxacin, 6% Gentamicin Fig.4(b). Staphylococcus 
aureus resistance to24% Oxacillin, 15% Erythromycin, 11% 
Ciprofloxacin, 9% Chloramphenicol, 8% Clindamycin, 8% 
Nitrofurantoin, 6% Linezolid, 4% Amikacin, 4% Gentamicin 
Fig.4(c). Pseudomonas aeruginosa resistance to 17% 
Ofloxacin, 14% Nalidixic acid, 14% Ceftriaxone, 10% 
Ampicillin/Sulbactam, 10% Gentamicin, 8% Ciprofloxacin, 
6% Amoxyclav, 6% Tobramycin, 4% Amikacin, 4% Cefaclor, 
4% Piperacillin/Tazobactam, 2% Meropenem Fig.4(d). 
Proteus sp resistance to 33% Meropenem, 33% Nalidixic 
acid, 33% Ofloxacin. 
  
 
15The mean susceptibility of uropathogens was for amikacin 
(AK-81%), nitrofurantoin (Nf-60%), cefotaxime (52%), 
ceftriaxone (Ci-47%), ciprofloxacin (Cf-45%), norfloxacin 
(Nx-33%), cotrimoxazole (Co-18%) and nalidixic acid (Na-
17%). 52% isolates were hemagglutinating, 34% were 
alpha-hemolytic, 31% were beta-hemolytic and 68% were 
motile reported. We isolated out of 103 isolates only 16.50% 
was the ability to produce hemolysis activity (Fig. 5).
  
 
Fig.5 
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CONCLUSION:  
HiCrome UTI Agar (M1353) chromogenic mixture to 
improve the colour characteristic of media. It recommended 
for the detection of urinary tract pathogens. It is used to 
identification of gram-negative and gram-positive bacteria 
on the basis of different colony colours produced by 
reactions of specific enzymes with two chromogenic 
substrates. This medium can be made selective by 
supplementation with antibiotics for detecting 
microorganisms associated with hospital-borne infections.6 
our finding concluded the Escherichia coli was the 
commonest cause of UTI. Most of the uropathogens are 
susceptible to amikacin (81%) and nitrofurantoin (60%)15. 
We studied the AST pattern of patients with UTI attending 
RMMCH, The study strongly recommends the need of each 
patient must analyze the antibiotic sensitivity test before 
taking off any treatment not only urine sample. The 
globalization was a very favorable condition for the super 
knowledge bacteria.  
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